Sterneck Capital Management Has Raised Its Vodafone Group Plc New (VOD) Holding; CVS Caremark Has 0.74 Sentiment

June 16, 2017 - By marketbeat

Sterneck Capital Management Llc increased Vodafone Group Plc New (VOD) stake by 1314.33% reported in 2016Q4 SEC filing. Sterneck Capital Management Llc acquired 131,433 shares as Vodafone Group Plc New (VOD)’s stock rose 16.21%. The Sterneck Capital Management Llc holds 141,433 shares with $3.46 million value, up from 10,000 last quarter. Vodafone Group Plc New now has $75.12B valuation. The stock rose 0.84% or $0.24 reaching $28.87 per share. About 2.84M shares traded. Vodafone Group Plc (ADR) (NASDAQ:VOD) has declined 13.23% since June 16, 2016 and is downtrending. It has underperformed by 29.93% the S&P500.

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The company has market cap of $77.24 billion. The Firm provides pharmacy care for the senior community through Omnicare, Inc. and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It has a 15.86 P/E ratio. It operates through three divisions: Pharmacy Services, Retail/LTC and Corporate.

Among 7 analysts covering Vodafone Group PLC (ADR) (NASDAQ:VOD), 2 have Buy rating, 1 Sell and 4 Hold. Therefore 29% are positive. Vodafone Group PLC (ADR) had 11 analyst reports since October 19, 2015 according to SRatingsIntel. The stock has “Buy” rating by Bank of America on Wednesday, April 20. The rating was downgraded by HSBC to “Hold” on Tuesday, January 17. The firm earned “Buy” rating on Monday, June 12 by Argus Research. The firm has “Outperform” rating by Macquarie Research given on Monday, October 19. The rating was initiated by Argus Research on Tuesday, September 20 with “Hold”. The rating was downgraded by Bank of America on Wednesday, January 25 to “Neutral”. Standpoint Research downgraded Vodafone Group Plc (ADR) (NASDAQ:VOD) on Thursday, June 1 to “Reduce” rating. The firm has “Buy” rating given on Tuesday, January 10 by Goldman Sachs. Standpoint Research initiated it with “Accumulate” rating and $30 target in Tuesday, January 3 report. The stock of Vodafone Group Plc (ADR) (NASDAQ:VOD) has “Neutral” rating given on Monday, November 21 by BNP Paribas.

Analysts await CVS Health Corp (NYSE:CVS) to report earnings on August, 1. They expect $1.31 earnings per share, down 0.76% or $0.01 from last year’s $1.32 per share. CVS’s profit will be $1.32B for 14.60 P/E if the $1.31 EPS becomes a reality. After $1.17 actual earnings per share reported by CVS Health Corp for the previous quarter, Wall Street now forecasts 11.97% EPS growth.

Cortland Associates Inc Mo holds 8.61% of its portfolio in CVS Health Corp for 537,274 shares. Grisanti Capital Management Llc owns 220,812 shares or 7.83% of their US portfolio. Moreover, Veritas Investment Management Llp has 7.78% invested in the company for 557,291 shares. The Illinois-based Dsc Advisors L.P. has invested 6.8% in the stock. Clark Estates Inc Ny, a New York-based fund reported 491,702 shares.

Since January 1, 0001, it had 0 insider purchases, and 7 sales for $40.53 million activity.